The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Meningococcal Vaccines Market


 Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome.

Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vaccines have been proven to be highly effective in preventing meningitis outbreaks and other meningeal disorders. They can also help boost a person’s immune system to increase his ability to fight off other viruses and diseases. It is important for a man with an unresponsive or weak immune system to receive an oral meningitis vaccine since he may still be at risk for contracting meningococcal diseases. Moreover, receiving an oral meningococcal vaccine can boost chances of developing a positive pregnancy outcome, thereby improving the fertility.

Market Dynamics                                               

The main driving factor influencing the growth of the meningococcal vaccines market is the increased number of people journeying to sub-Saharan Africa. For instance, according to a 2018 report by World Economic Forum, 87.4 million arrivals were recorded in the region s of Sub-Saharan Africa. Moreover, various regulatory bodies recommending meningococcal vaccination is also estimated to propel the market growth. For instance, the Centers for Disease Control and Prevention (CDC) has recommended meningococcal vaccines for teens and preteens.

However, notable variations in epidemiology and incidences of meningococcal vaccines have been recorded in various places. The risks associated with tourists are unpredictable and that makes it tougher to provide proof-based recommendations of the vaccines and this is acting as the main restraining factor hindering the market growth. Moreover, meningococcal vaccines are optional in many nations and are expected to hinder market growth.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these, North America is expected to hold a bigger share of the meningococcal vaccines market owing to the favorable support and recommendation from the government and high investments in the research and development sector. For instance, in 2019 December, National Advisory Committee on Immunization (NACI), published some scientific data and recommendations regarding Trumenba, which is a MenB-fHBP vaccine. The meningococcal vaccines market in the Asia Pacific is estimated to witness significant growth owing to the rapid initiatives taken by governmental and authoritarian bodies to fight against the increasing prevalence of the disease and the growth of the pediatric population.

Competitive Analysis

Major players operating in the global meningococcal vaccines market include Serum Institute of India Ltd., Sanofi SA, Pfizer Inc., Novartis International AG., JN-International Medical Corporation, GlaxoSmithKline plc, Biomed Pvt. Ltd., and Baxter International Inc.

In April 2020, Sanofi’s Biologics License Application for MenQuadfi Meningococcal (Groups A, C, Y, W) Conjugate Vaccine was approved by The U.S. Food and Drug Administration (FDA). Likewise, in September 2019, the Serum Institute of India Pvt. Ltd. established a new processing plant in Pune, Maharashtra, India.

Comments

Post a Comment

Popular posts from this blog

The Global Voice Prosthesis Devices Market Is Giving Voice to People with Voice Disabilities Caused Due To Surgery or Cancer and Key Players Are Trying To Make New Devices More Affordable

Image
  A voice prosthesis device is an electronic device, often made from silicon, which is used in combination with voice therapy for patients who have voice disorders and to aid those who suffer from vocal cord injuries. During a full vocal cordectomy, the vocal cords are completely removed and the airway and larynx are separated by a small incision. Voice prosthetics include full body units that can be worn as regular items and even become a part of the natural appearance of the body. Some patients choose to wear their prosthetics only during use while others prefer to wear them all the time. Some voice prosthetic devices are completely removable, while others have to be surgically installed or removed. As the number of people who need help with everyday communication increases, more are finding themselves in need of these devices. Market Dynamics                      ...
Read more

Growing Prevalence of Respiratory Disorder Around the Globe is Escalating Growth of the Respiratory Trainer Market

Image
 A respiratory trainer is a medical device that helps to prevent the spread of germs, allergies, and air borne diseases. It has many parts like a face mask, biological gauge, pressure garments, pressure band, nose clips, pressure equalizer, and air ventilation system. The Respiratory Trainer also helps to correct problems like sleep apnea, snoring, coughing, wheezing, and labored breathing. It is generally used in homes for preventing asthma attacks and reducing the chances of attack or disability. A respiratory trainer comprises two outer parts; the inner part consists of biological feedback device with electronic sensors and a mechanical valve; the outer part is a comfortable full-body cycling top. A respiratory Trainer is used to dilate airways, strengthening the diaphragm, enhancing lung expansion and increasing the residual volume of air breathed by the lungs. Residual volume refers to residual blood gas and residual blood volume (RV) of the lungs. The growing prevalence of re...
Read more